Mindset towards Adapting: Tom Seaman and Scott Davidson Discuss Chronic Illness and Accepting Change

This is an interview I did with Scott Davidson who has a podcast called Living Adaptive, where he interviews people that have adapted to significantly difficult situations in their lives.…

Continue Reading Mindset towards Adapting: Tom Seaman and Scott Davidson Discuss Chronic Illness and Accepting Change
Experimental Treatment for Biliary Atresia Gets Orphan Drug Designation in the EU
Capri23auto / Pixabay

Experimental Treatment for Biliary Atresia Gets Orphan Drug Designation in the EU

According to a story from Market Screener, the drug developer Albireo Pharma, Inc., recently announced that its investigational product candidate A4250 has earned Orphan Drug designation from the European Commission.…

Continue Reading Experimental Treatment for Biliary Atresia Gets Orphan Drug Designation in the EU
Device Allows Monitoring of Lung Function at Home For Duchenne Muscular Dystrophy Patients
Myriams-Fotos / Pixabay

Device Allows Monitoring of Lung Function at Home For Duchenne Muscular Dystrophy Patients

According to a story from EurekAlert!, monitoring lung function is an important role of managing Duchenne muscular dystrophy and other diseases that can cause wasting of the respiratory muscles. Many…

Continue Reading Device Allows Monitoring of Lung Function at Home For Duchenne Muscular Dystrophy Patients
Possible Treatment for Spinal Muscular Atrophy Gains PRIME Designation From the EMA
Belova59 / Pixabay

Possible Treatment for Spinal Muscular Atrophy Gains PRIME Designation From the EMA

According to a story from pm360online.com, the pharmaceutical company Roche recently announced that its investigational therapy risdiplam has awarded PRIME designation from the European Medicines Agency (EMA). The drug has…

Continue Reading Possible Treatment for Spinal Muscular Atrophy Gains PRIME Designation From the EMA
Potential Treatment for Lupus is Granted Fast Track Designation From the FDA
frolicsomepl / Pixabay

Potential Treatment for Lupus is Granted Fast Track Designation From the FDA

According to a story from BioSpace, Incyte Corporation and Eli Lilly and Company recently announced that the US Food and Drug Administration (FDA) has given the drug baricitinib Fast Track…

Continue Reading Potential Treatment for Lupus is Granted Fast Track Designation From the FDA